These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11153737)

  • 1. Non-Q-wave myocardial infarction following thrombolytic therapy: a comparison of outcomes in patients randomized to invasive or conservative post-infarct assessment strategies in the Veterans Affairs non-Q-wave Infarction Strategies In-Hospital (VANQWISH) Trial.
    Wexler LF; Blaustein AS; Lavori PW; Lehmann KG; Wade M; Boden WE
    J Am Coll Cardiol; 2001 Jan; 37(1):19-25. PubMed ID: 11153737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators.
    Boden WE; O'Rourke RA; Crawford MH; Blaustein AS; Deedwania PC; Zoble RG; Wexler LF; Kleiger RE; Pepine CJ; Ferry DR; Chow BK; Lavori PW
    N Engl J Med; 1998 Jun; 338(25):1785-92. PubMed ID: 9632444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and baseline characteristics of the Veterans Affairs Non-Q-Wave Infarction Strategies In-Hospital (VANQWISH) trial. VANQWISH Trial Research Investigators.
    Ferry DR; O'Rourke RA; Blaustein AS; Crawford MH; Deedwania PC; Carson PE; Pepine CJ; Thomas RG; Hlatky MA; Leppo JA; Iwane MK; Kleiger RE; Zoble RG; Dai H; Chow BK; Lavori PW; Boden WE
    J Am Coll Cardiol; 1998 Feb; 31(2):312-20. PubMed ID: 9462573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction.
    Anderson HV; Cannon CP; Stone PH; Williams DO; McCabe CH; Knatterud GL; Thompson B; Willerson JT; Braunwald E
    J Am Coll Cardiol; 1995 Dec; 26(7):1643-50. PubMed ID: 7594098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.
    Circulation; 1994 Apr; 89(4):1545-56. PubMed ID: 8149520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An ischemia-guided approach for risk stratification in patients with acute coronary syndromes.
    Pepine CJ
    Am J Cardiol; 2000 Dec; 86(12B):27M-35M. PubMed ID: 11206016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early invasive versus ischaemia-guided strategies in the management of non-Q wave myocardial infarction patients with and without prior myocardial infarction; results of Veterans Affairs Non-Q Wave Infarction Strategies in Hospital (VANQWISH) trial.
    Heggunje PS; Wade MJ; O'Rourke RA; Kleiger RE; Deedwania PC; Lavori PW; Boden WE;
    Eur Heart J; 2000 Dec; 21(24):2014-25. PubMed ID: 11102252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of a conservative, ischemia-guided management strategy after non-Q-wave myocardial infarction: results of a randomized trial.
    Barnett PG; Chen S; Boden WE; Chow B; Every NR; Lavori PW; Hlatky MA
    Circulation; 2002 Feb; 105(6):680-4. PubMed ID: 11839621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy. Thrombolysis In Myocardial Infarction.
    Cannon CP; Weintraub WS; Demopoulos LA; Robertson DH; Gormley GJ; Braunwald E
    Am J Cardiol; 1998 Sep; 82(6):731-6. PubMed ID: 9761082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive vs conservative management of non-Q-wave myocardial infarction.
    Patel VB; Moliterno DJ
    Cleve Clin J Med; 1999 Feb; 66(2):100-4. PubMed ID: 9988955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of late elective angioplasty versus conservative management for patients with residual stenoses after thrombolytic treatment of myocardial infarction. Treatment of Post-Thrombolytic Stenoses (TOPS) Study Group.
    Ellis SG; Mooney MR; George BS; da Silva EE; Talley JD; Flanagan WH; Topol EJ
    Circulation; 1992 Nov; 86(5):1400-6. PubMed ID: 1423952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features and long-term outcome of non-Q wave myocardial infarction in the elderly: comparison with Q wave myocardial infarction].
    Kishi K; Hiasa Y; Kinoshita M; Kondoh N; Fujinaga H; Ohtani R; Wada T; Aihara T
    J Cardiol; 1994; 24(6):433-7. PubMed ID: 7823281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive versus conservative strategy after thrombolytic therapy for acute myocardial infarction in patients with antecedent angina. A report from Thrombolysis in Myocardial Infarction Phase II (TIMI II).
    Ruocco NA; Bergelson BA; Jacobs AK; Frederick MM; Faxon DP; Ryan TJ
    J Am Coll Cardiol; 1992 Dec; 20(7):1445-51. PubMed ID: 1452916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of coronary revascularization in patients with unstable and non-ST-segment elevation acute myocardial infarction.
    Popma JJ; Suk J
    Am J Cardiol; 2001 Oct; 88(8A):25K-29K. PubMed ID: 11694216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is ST segment elevation non-Q-wave myocardial infarction after thrombolytic therapy a new clinical entity that requires an invasive management strategy?
    Chaitman BR; Bitar SR
    J Am Coll Cardiol; 2001 Jan; 37(1):26-9. PubMed ID: 11153749
    [No Abstract]   [Full Text] [Related]  

  • 16. The non-Q wave myocardial infarction revisited: 10 years later.
    Liebson PR; Klein LW
    Prog Cardiovasc Dis; 1997; 39(5):399-444. PubMed ID: 9122424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of patients with a first non-Q-wave myocardial infarction before and in the reperfusion era. SPRINT and the Israeli Thrombolytic Survey Groups. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
    Haim M; Gottlieb S; Boyko V; Reicher-Reiss H; Hod H; Kaplinsky E; Mandelzweig L; Goldbourt U; Behar S
    Am Heart J; 1998 Aug; 136(2):245-51. PubMed ID: 9704685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial.
    Rogers WJ; Baim DS; Gore JM; Brown BG; Roberts R; Williams DO; Chesebro JH; Babb JD; Sheehan FH; Wackers FJ
    Circulation; 1990 May; 81(5):1457-76. PubMed ID: 2110033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excimer laser in myocardial infarction: a comparison between STEMI patients with established Q-wave versus patients with non-STEMI (non-Q).
    ; Topaz O; Ebersole D; Dahm JB; Alderman EL; Madyoon H; Vora K; Baker JD; Hilton D; Das T
    Lasers Med Sci; 2008 Jan; 23(1):1-10. PubMed ID: 17426922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory.
    Kerensky RA; Wade M; Deedwania P; Boden WE; Pepine CJ;
    J Am Coll Cardiol; 2002 May; 39(9):1456-63. PubMed ID: 11985907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.